Dr Deanna Windham, LDN Radio Show (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Dr Deanna Windham shares her Low Dose Naltrexone (LDN) experience on the LDN Radio Show with Linda Elsegood.

Dr Bruce Berman, LDN Radio Show 2016 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Linda Elsegood: I'm joined today by Dr Bruce Berman from sunny Florida in the US thanks for joining me, Bruce. 

Dr Bruce Berman: My pleasure. 

P418 Low dose naltrexone in therapy resistant IBD, a case series

J Crohn's and Colitis
February 2014
https://www.gastrojournal.org/article/S0016-5085(14)61660-7/pdf

The Effect of Low-Dose Naltrexone on Medication in Inflammatory Bowel Disease: A Quasi Experimental Before-and-After Prescription Database Study

Erratum: Corrigendum: The Effect of Low-Dose Naltrexone on Medication in Inflammatory Bowel Disease: A Quasi Experimental Before-and-After Prescription Database Study.
J Crohns Colitis
10 December 2019
https://pubmed.ncbi.nlm.nih.gov/31499520/

Low-Dose Naltrexone in Diseases' Treatment: Global Review

Naltrexone Therapy for Crohn’s Disease and Ulcerative Colitis

Journal of Clinical Gastroenterology
September 2014
https://journals.lww.com/jcge/Citation/2014/09000/Naltrexone_Therapy_for_Crohn_s_Disease_and.18.aspx

Low Dose Naltrexone Reduces In Vitro Endoplasmic Reticulum Stress and Stimulates Wound Healing in Intestinal Epithelial Cells

Journal of Crohn's and Colitis
March 2016
https://academic.oup.com/ecco-jcc/article/10/suppl_1/S136/2481649

 

Leonard Weinstock, MD - Ulcerative Colitis (2016 Conference) (LDN, low dose naltrexone)

Download Dr. Weinstock's Ulcerative Colitis Presentation

 

Leonard Weinstock, MD - Inflammatory Bowel Disease II (2017 Conference) (LDN, low dose naltrexone)

Inflammatory bowel disease is a condition that we see as gastroenterologists on a daily basis. I'm Dr. Weinstock. I'd like to review inflammatory bowel disease, what the traditional approaches are, and some of the newer changes that we've seen with low dose naltrexone. Here are my disclosures.